Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 124655-09-0 | MDL No. : | MFCD08063915 |
Formula : | C13H24O5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | CFRUAOXMCVQMFP-ZJUUUORDSA-N |
M.W : | 260.33 | Pubchem ID : | 9816650 |
Synonyms : |
|
Num. heavy atoms : | 18 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.92 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 67.18 |
TPSA : | 64.99 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.16 cm/s |
Log Po/w (iLOGP) : | 3.03 |
Log Po/w (XLOGP3) : | 1.03 |
Log Po/w (WLOGP) : | 1.62 |
Log Po/w (MLOGP) : | 0.88 |
Log Po/w (SILICOS-IT) : | 1.79 |
Consensus Log Po/w : | 1.67 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.77 |
Solubility : | 4.39 mg/ml ; 0.0169 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.98 |
Solubility : | 2.7 mg/ml ; 0.0104 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.91 |
Solubility : | 3.2 mg/ml ; 0.0123 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 4.09 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | Stage #1: With dimethyl sulfoxide; N-ethyl-N,N-diisopropylamine In dichloromethane at -5 - 0℃; for 0.5 h; Stage #2: With pyridine; sulfur trioxide pyridine complex; dimethyl sulfoxide In dichloromethane at -5 - 20℃; for 1.16667 h; |
(4R-cis)-6-(hydroxymethyl)-2,2-dimethyl- 1 ,3 -dioxane-4-acetic acid, 1 , 1 -dimethyl ethyl ester (10.0 g ,0.0385 mol) mol) was dissolved in dimethyl sulfoxide (15.0 g , 0.192 mol) and dichloromethane (100 ml) followed by cooling at 0 to -5 0C. The reaction mass was cooled for 15 min at 0 to -5 0C followed by addition of Diisopropylethyl amine( 17.42 g ,0.1347 mol) at 0 to -5 0C and continued stirring for 15 min at 0 to -5 0C. In another flask, charged pyridine-sulfur trioxide complex (12.25 g, 0.077 mol), pyridine (6.09 g, 0.077 mol) and dimethyl sulfoxide (15.0 g, 0.192 mol) at room temperature followed by stirring for 10 min. Resulting suspension was added to the above alcohol solution in dichloromethane at 0 to -5 0C and continued stirring for 1 hr at 0 to -5 0C. After the completion of reaction, water (50.0 ml) was added and stirred for 10 min. This was followed by layer separation. Aqueous layer was extracted with dichloromethane (2 x 20 ml).Dichloromethane layer was washed with water ( 3 x 100.0 ml ) followed by drying over sodium sulfate and distilled dichloromethane under vacuum at 40 to 45.0 °C.Degased mass for 1 hr at 40 to 45.0 0C under reduced pressure to obtain tertiary butyl-2-[(4R,6S)-6-formyl-2,2-dimethyl-l,3-dioxan-4-yl] acetate, compound of formula II (9.22 g, 93.0percent). |
86% | With tetrapropylammonium perruthennate; 4-methylmorpholine N-oxide In dichloromethane; acetonitrile at 0 - 25℃; for 5.5 h; Molecular sieve | (6-Formyl-2, 2-dimethyl- [1, 3] dioxan-4-yl)-acetic acid tert-butyl ester To a solution of (6-hydroxymethyl-2. 2-dimethyl-11, 3] dioxan-4-yl)-acetic acid tert- butyl ester (30.0 g, 115 mmol) at 0 °C in DCM: MeCN (10: 1,225 mL) was added 4 A molecular sieves (55 g), 4-methylmorpholine N-oxide (20. 3 g, 172.9 mmol) and tetrapropylammonium perruthenate (0.41 g, 1. 15 mmol). The reaction was warmed from 0 °C to 25 °C over 0.5 hr and then stirred at that temperature for 5 hrs. Once complete, as determined by TLC, the reaction mixture was filtered through celite and the filtrate was concentrated to a brown oil that was purified by silica gel chromatography (20-70 percent EtOAc/Hexane) to provide (6-formyl-2, 2-dimethyl- [1, 3] dioxan-4-yl)-acetic acid tert-butyl ester (25.5 g, 86percent): H-NMR (CDCI3) 09. 54 (s, 1 H), 4.30-4. 26 (m, 2 H), 2.45-2. 39 (m, 1 H), 2.33-2. 27 (m, 1 H), 1.81-1. 77 (m, 1 H), 1.46-1. 41 (m, 16 H), 1.28-1. 20 (m, 1 H). |
85.9% | With 2,2,6,6-tetramethyl-piperidine-N-oxyl; sodium hypochlorite; sodium hydrogencarbonate; potassium bromide In dichloromethane at -15 - 0℃; | (2) step (1) to obtain compound II of the methylene chloride solution, adding 0.15g (0.99mmol) TEMPO, 2.36g (0.0198mol) potassium bromide and 16.6g (0.198mol) sodium bicarbonate, stirring and mixing after cooling to -15 °C, dropping pre-adjusting the pH to 10 sodium hypochlorite solution (175.9g (0.238mol) sodium hypochlorite solution (content 10.9percent) in terms of mass percentage concentration is 5percent sulfuric acid adjusted to pH 10), control reaction solution temperaturethe <0 °C.drop finishes, 0 °C stirring for reaction, GC tracking of the reaction, the response finishes (compound III less than0.2percent)adding quality percentage concentration is 10percent aqueous solution of sodium thiosulfate 156.5g stirring quenching reaction, the resulting organic phase after transferring, to 300g × 2 washing, to obtain light yellow clear solution, adding 50g drying by anhydrous sodium sulfate, filter, to 20g dichloromethane wash the filter cake, the spin vaporization (40 °C, -0.09 MPa) unless the solvent to obtain strawcoloured solid 46.0g, yield 90.1percent, GC purity 98.7percent, crude I is compound; |
83% | With sodium hypochlorite; 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; sodium hydrogencarbonate; potassium bromide In dichloromethane; water at -15 - 5℃; for 1 h; Large scale | 0.02 g of TEMPO (2,2,6,6-tetramethyl-1-piperidinyloxy free radical), 0.96 g of potassium bromide, 18.6 g of sodium hydrogencarbonate and 50 ml of methylene chloride were placed in a 500 ml flask, Stirred at ~ 5 ° C.After dissolving 11.64 g (44.71 mmol) of t-butyl 2 - [(4R, 6S) -6-hydroxymethyl-2,2-dimethyl- 1,3-dioxane- 4-yl] acetate in 50 ml of methylene chloride , Added to the above reaction. After cooling the reaction product to -15 ° C. or lower, 36.6 ml (53.65 mmol, 1.2 equivalent) of a 10.9percent (w / w) sodium hypochlorite aqueous solution was added dropwise at once. After the dropwise addition, stirring was carried out at 0 ° C. for 1 hour, the reaction progress degree was checked by gas chromatography (GC), the reaction product was filtered under reduced pressure, 10percent sodium thiosulfate solution (10 w / wpercent sodium thiosulfate solution) 100 ml was added and the organic layer was separated. 100 ml of a saturated sodium chloride solution was added to the organic layer, and the organic layer was further separated. After adding 150 ml of water to the organic layer and stirring for 10 minutes, the stagnant organic layer was separated, dried over anhydrous magnesium sulfate, filtered, methylene chloride as an organic solvent was distilled under reduced pressure at 40 ° C. and 3 cmHg for 10 minutes To obtain a concentrated residue 1 as an oil phase (step A).The concentrated residue 1 was adjusted to a pressure of 3 cmHg in a vacuum vacuum dryer and dried for 30 minutes at 80 ° C. without separately adjusting the humidity to obtain the title compound as pale brown crystals (Step B) . (The XRD graph of the product is shown in Figure 1 and its value is as shown in Figure 2. The DSC value of the product is shown in Figure 3.) Yield of product 83percent (8.2kg) |
54% | With sodium hypochlorite; TEMPOL; sodium hydrogencarbonate; potassium bromide In water; ethyl acetate at -10 - 5℃; for 1 h; Inert atmosphere | Reference Example 2: tert-Butyl 2-[(4R,6S)-6-formyl-2,2-dimeihyl-1, 3-dioxane-4-yl] acetate [Show Image] To a dispersion of tert-butyl 2-[(4R,6S)-6-hydroxymethyl-2,2-dimethyl-1,3-dioxane-4-yl] acetate (15 g, 57.6 mmol), sodium hydrogencarbonate (13.6 g, 161.3 mmol), potassium bromide (1.37 g, 11.5 mmol) and 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine-1-oxyl free radical (248 mg, 1.44 mol) in ethyl acetate (150 ml), an aqueous solution of sodium hypochlorite (44.2 g, 16.7wtpercent, 70.2 mmol) was added under nitrogen stream at -10°C carefully dropwise to keep the inner temperature within 5°C. After the dropwise addition, the mixture was stirred at 0°C for 1 hour and the aqueous layer was separated. The organic layer was further diluted with ethyl acetate (100 ml), and sequentially washed with a 5percent sodium thiosulfate aqueous solution (75 ml) and water (40 ml .x. 2). Then, the organic layer was dried with anhydrous magnesium sulfate. The solvent was distilled away under reduced pressure, and the obtained crude product was purified with silica gel column chromatography (silica gel: 200 g, developing solvent: hexane / ethyl acetate = 2 / 1 by volume) to obtain the title compound (8.0 g, yield: 54percent) as white crystals. 1H-NMR (CDCl3): δ1.35(1H, q, J=12.7Hz), 1.45 (9H, s), 1.46 (3H, s), 1.49(3H, s), 1.83(1H, dt, J=2.7Hz, 12.9Hz), 2.35(1H, dd, J=5.9Hz, 15.4Hz), 2.46(1H, dd, J=7.1Hz, 15.4Hz), 4.33(1H, m), 9.58 (1H, s) |
19.2 g | Stage #1: With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical; sodium hydrogencarbonate; potassium bromide In dichloromethane at 0 - 5℃; for 0.25 h; Stage #2: With sodium hypochlorite; sodium hydrogencarbonate In dichloromethane; water at 0 - 5℃; for 1.66667 h; |
Preparation of Tert-Butyl 3,5-Dideoxy-2,4-O-(1-Methylethylidene)-L-Erythro-Hexuronate tert-Butyl 2,4-dideoxy-3,5-O-(1-methylethylidene)-D-erythro-hexonate (commercially available; 20 g) was added to a pre cooled (0° C. to 5° C.) mixture of 2,2,6,6-tetramethylpiperidine-1-oxyl (0.04 g), potassium bromide (1.92 g), and sodium bicarbonate (18 g) in dichloromethane (120 mL) and stirred at 0° C. to 5° C. for 15 minutes. Aqueous sodium hypochlorite (10percent; 40 mL) was added slowly to the resulting mixture and stirred at 0° C. to 5° C. for 30 minutes. Sodium bicarbonate (18 g) was added to the mixture and stirred at 0° C. to 5° C. for 10 minutes, followed by the slow addition of aqueous sodium hypochlorite (10percent; 40 ml) in 30 minutes at 0° C. to 5° C. The reaction mixture was stirred at 0° C. to 5° C. for 30 minutes. After completion of the reaction, the reaction mixture was filtered through hyflo bed and washed with dichloromethane (20 mL). The filtrate was washed with aqueous sodium thiosulphate (10percent; 100 mL). The organic layer was separated and washed with de-ionized water (100 mL) and finally washed with aqueous solution of sodium chloride (10percent; 100 mL). The organic layer was separated and concentrated under vacuum at 40° C. to give tert-butyl 3,5-dideoxy-2,4-O-(1-methylethylidene)-L-erythro-hexuronate. Dry weight: 19.2 g. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86% | Stage #1: With pyridine In dichloromethane at 20℃; for 0.5 h; Stage #2: at 20℃; for 1 h; |
The compound of formula (I-1){Tert-butyl 2 - ((4R, 6S) -6- (hydroxymethyl) -2,2-dimethyl-1,3-dioxan-4-yl) acetate}(1.0 g, 3.84 mmol, Jiangsu Alpha Pharmaceutical) was dissolved in 10 ml of methylene chloride (MC), pyridine (0.9 g, 11.52 mmol) was added at room temperature, and the mixture was stirred at room temperature for 30 minutes.Acetyl chloride (0.66 g, 8.45 mmol) was added and the mixture was stirred at room temperature for 1 hour. 10 ml of water was added to the reaction mixture, and the mixture was stirred for 10 minutes, and the organic layer was separated. After 5 ml of methylene chloride was extracted twice, 10 ml of water was added thereto, followed by stirringThe organic layer was separated. The organic layer was dried over anhydrous magnesium sulfate, filtered, and distilled under reduced pressure to obtain 0.98 g (yield: 86percent) of the compound of the formula I-2 in the form of a pale pink crystal. |
[ 93635-76-8 ]
(2S,3R)-Ethyl 3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,3-dihydroxy-2-methylpropanoate
Similarity: 0.87
[ 189509-22-6 ]
Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate
Similarity: 0.86
[ 82578-45-8 ]
(S)-tert-Butyl 3-hydroxybutanoate
Similarity: 0.74
[ 83540-97-0 ]
(R)-Diisopropyl 2-hydroxysuccinate
Similarity: 0.73
[ 124752-23-4 ]
tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate
Similarity: 0.90
[ 93635-76-8 ]
(2S,3R)-Ethyl 3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,3-dihydroxy-2-methylpropanoate
Similarity: 0.87
[ 189509-22-6 ]
Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate
Similarity: 0.86
[ 6413-10-1 ]
Ethyl 2-(2-methyl-1,3-dioxolan-2-yl)acetate
Similarity: 0.83
[ 125995-13-3 ]
(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate
Similarity: 0.82
[ 124752-23-4 ]
tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate
Similarity: 0.90
[ 93635-76-8 ]
(2S,3R)-Ethyl 3-((R)-2,2-dimethyl-1,3-dioxolan-4-yl)-2,3-dihydroxy-2-methylpropanoate
Similarity: 0.87
[ 189509-22-6 ]
Ethyl 2-(8-hydroxy-1,4-dioxaspiro[4.5]decan-8-yl)acetate
Similarity: 0.86
[ 6413-10-1 ]
Ethyl 2-(2-methyl-1,3-dioxolan-2-yl)acetate
Similarity: 0.83
[ 125995-13-3 ]
(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate
Similarity: 0.82
[ 124752-23-4 ]
tert-Butyl (4R-cis)-6-formaldehydel-2,2-dimethyl-1,3-dioxane-4-acetate
Similarity: 0.90
[ 125995-13-3 ]
(4R,6R)-tert-Butyl-6-(2-aminoethyl)-2,2-dimethyl-1,3-dioxane-4-acetate
Similarity: 0.82
[ 866594-60-7 ]
(3aS,4S,6aR)-4-Methoxytetrahydrofuro[3,4-b]furan-2(3H)-one
Similarity: 0.81
[ 58093-05-3 ]
6,10-Dioxaspiro[4.5]decane-7,9-dione
Similarity: 0.79